Precision Health Intelligence Infrastructure
Transforming genomic data, metabolic pathway logic, biomarker observations, and lifestyle inputs into predictive biological intelligence.
Scroll to explore
22M+Scientific publications indexed
15+Years evidence repository
10+Countries active globally
70+Genetic panel domains
2.2M+Genomic tests processed
What makes Precisya different
A glimpse into the science, scale and intelligence that sets Precisya apart
Scientific Foundation
22M+
Scientific publications in Precisya's proprietary genomic database
Aggregated over 15 years of continuous research: the world's largest genomic intelligence repository powering every panel and pathway analysis.
12+ algorithms
Only 6% inclusion rate
15 years of R&D
Publications vs utilised
Total assessed
22M+
Precision-validated
6%
Stringent inclusion and exclusion criteria ensure every data point earns its place in the intelligence engine.
Gene Coverage
952genes
In a single Nutrition panel alone
Competitors analyse 21. Precisya analyses 952. Across 70+ panels, every condition is mapped at a depth the industry has never attempted.
952
Precisya
Ethnicity Intelligence
The same gene variant carries a different risk in different populations
Every other system ignores this. Precisya's Ethnicity-Based Score of Risk (EBSR) calibrates every result to your patient's actual genetic background.
Patient
Eth 1
Eth 6
Same genotype. Six different risk profiles. Precisya calibrates for all.
Panel Portfolio
70+
Clinically actionable genetic panels across every medical discipline
Oncology
Cardiovascular
Neurology
Longevity
Fertility
Nutrition
Autism
+ 63 more
Genomic Depth
Exome NGS
vs
Precisya GbS
800,000+ genetic variants analysed per patient
Standard tests cover less than 2% of DNA. Precisya's Genotyping by Sequencing reads both exons and introns, the regulatory layer no competitor touches.
What Precisya offers
One scientific infrastructure, multiple intelligence layers
Navigate to each section to explore Precisya's full capability stack from platform science to global deployments.
Deep Health Tech
Platform science, pathway intelligence, systems biology methodology, and the full scientific validity and evidence base.
Solutions
Enterprise, education, sports, and longevity deployments one infrastructure, multiple high-value market applications.
Genetic Panels
70+ modular panels spanning oncology, metabolism, neurology, fertility, performance, and rare conditions.
Team and Global Reach
Validated across diverse populations in 14 countries across Europe, the Middle East, South America, and Asia.
Resources
Technical and scientific content, partner access protocols, and direct contact for institutional collaboration.
From data to decision intelligence
How Precisya turns biological complexity into actionable insight
Precisya bridges the gap between raw genomic data and real clinical decisions, empowering clinicians and patients alike with intelligence that is personalised, evidence-based, and continuously evolving.
Deep Health Tech
A scientific platform built on systems biology
Precisya integrates static biological predisposition with dynamic clinical observations to provide a scalable precision health intelligence layer interpreting biology at the pathway level, not the variant level.
22M+ publications
12+ algorithms
800K+ variants per patient
70+ panels
Scientific Data Engine
Proprietary engine built from 22M+ publications and refined through continuous algorithmic evolution since 2011, with 15+ years of evidence repository depth.
Pathway Intelligence
Interprets interference patterns across methylation, oxidation, inflammation, neuro-signaling, insulin regulation, and longevity pathways.
Clinical Correlation Layer
Bridges genomics with blood biomarkers, questionnaire signals, symptoms, and real-world health contexts through validated gene-biomarker associations.
Predictive Modeling
Highlights biological drift, system burden, and optimization priorities before disease becomes clinically dominant enabling early intervention.
Multi-Ethnicity Precision
Population-specific genetic modeling accounting for allele frequency variations and ethnicity-based risk profiles across 10+ global populations.
Explainable Infrastructure
Built as an explainable decision support environment with traceable, bibliography-backed reporting for transparency and reproducibility.
Scientific Validity & Methodology
Institutional-grade scientific rigour
Precisya's methodology is grounded in peer-reviewed science, internationally accredited laboratory standards, and validated computational frameworks.
Laboratory Standards
CLIA-certified & CAP-accredited
All genomic analyses are conducted through CLIA-certified and CAP-accredited laboratories, adhering to guidelines from the American College of Medical Genetics (ACMG). Quality assurance processes include standardised sequencing protocols, internal controls, and external proficiency testing.
CLIA Certified
CAP Accredited
ACMG Aligned
Computational Methodology
Proprietary algorithmic innovations
Precisya's platform applies strand orientation normalisation, multi-ethnicity precision breakdown analysis, and AI-enabled correlation modeling across genetic variants, biomarkers, symptoms, and lifestyle factors. Outputs are probabilistic, evidence-informed, and professionally interpreted.
Strand Inversion Algorithm
Polygenic Modeling
Reverse Inference
Systems Biology Framework
Health and disease treated as emergent properties of interconnected biological networks not isolated gene effects. Perturbations modeled across metabolic, inflammatory, neurological, and hormonal systems.
Whole-Body Pathway Mapping
Genetic variants mapped across comprehensive metabolic pathways using KEGG and Reactome. Captures cross-system cascades and feedback loops rather than isolated pathway effects.
Genetic Interference Modeling
Combined effects of multiple genetic variants analyzed to identify interference patterns aligned with polygenic modeling and epistasis, where gene-gene interactions produce non-linear biological outcomes.
Upstream/Downstream Modeling
Distinguishes upstream biological drivers (genetic variation, enzymatic inefficiencies) from downstream clinical manifestations (biomarker deviations, symptoms) enabling root-cause oriented interpretation.
Longevity & Dynamic Modeling
Incorporates dynamic health indicators biological age, circadian patterns, post-prandial responses grounded in chronobiology, metabolic research, and aging science for longitudinal trajectory analysis.
Clinical Translation Layer
Complex biological data translated into structured, actionable insights aligned with clinical workflows. Supports personalised interventions across nutrition, lifestyle, and preventive health strategies.
Master Genomic Databases
Built on the world's most authoritative biological databases
All genomic analyses are mapped against curated, internationally recognised databases the same foundations used by leading research institutions globally.
| # | Database / Standard | Domain | Institution |
|---|---|---|---|
| 1 | KEGG Kyoto Encyclopedia of Genes and Genomes | Metabolic Pathways | Kanehisa & Goto 2000 |
| 2 | Reactome Pathway Knowledgebase | Pathway Analysis | Fabregat et al. 2018 |
| 3 | HMDB Human Metabolome Database | Metabolomics | Wishart et al. 2018 |
| 4 | ACMG Standards & Guidelines | Lab Accreditation | ACMG 2015 |
| 5 | ClinVar | Variant Interpretation | Landrum et al. 2018 |
| 6 | dbSNP | SNP Reference | Sherry et al. 2001 |
| 7 | gnomAD | Population Allele Frequencies | Karczewski et al. 2020 |
| 8 | DisGeNET | Gene-Disease Associations | Piñero et al. 2017 |
| 9 | PharmGKB | Pharmacogenomics | Whirl-Carrillo et al. 2021 |
| 10 | GWAS Catalog | Association Studies | MacArthur et al. 2017 |
Scientific Evidence Base
Grounded in peer-reviewed literature across every biological domain
Examples of foundational peer-reviewed references spanning systems biology, precision medicine, cardiovascular genetics, oncogenomics, neurology, endocrinology, reproductive health, and longevity science.
Systems Biology & Precision Medicine
Foundational scientific frameworks
1.Barabási AL, et al. Network medicine: a network-based approach to human disease. Nat Rev Genet. 2011;12(1):56-68.
2.Kitano H. Systems biology: a brief overview. Science. 2002;295(5560):1662-1664.
3.Ashley EA. Towards precision medicine. Nat Rev Genet. 2016;17(9):507-522.
4.Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med. 2015;372:793-795.
5.Hood L, Friend SH. Predictive, personalized, preventive, participatory medicine. Nat Rev Drug Discov. 2011;10:184-190.
6.Topol EJ. Individualized medicine from prewomb to tomb. Cell. 2014;157(1):241-253.
7.Hasin Y, et al. Multi-omics approaches to disease. Genome Biol. 2017;18:83.
8.Visscher PM, et al. 10 years of GWAS discovery. Am J Hum Genet. 2017;101(1):5-22.
Cardiovascular Genetics
Blood pressure, lipids, thrombosis & homocysteine
27.Lifton RP, et al. Molecular mechanisms of human hypertension. Cell. 2001;104(4):545-556.
28.Ehret GB, et al. Genetic variants in novel pathways influence blood pressure. Nature. 2011;478:103-109.
29.Willer CJ, et al. Discovery and refinement of loci associated with lipid levels. Nat Genet. 2013;45:1274-1283.
30.Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet. 1999;353(9159):1167-1173.
31.Frosst P, et al. A candidate genetic risk factor for vascular disease: MTHFR mutation. Nat Genet. 1995;10:111-113.
32.Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease. JAMA. 2002;288:2015-2022.
Oncogenomics
Breast, endometrial, ovarian & lung cancer genetics
34.Miki Y, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266:66-71.
35.Wooster R, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995;378:789-792.
36.Pharoah PD, et al. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet. 2002;31:33-36.
37.Spurdle AB, et al. GWAS identifies common variant associated with endometrial cancer. Nat Genet. 2011;43:451-454.
Neurology & Longevity
Parkinson's, BDNF, oxidative stress & aging
38.Singleton AB, et al. Alpha-synuclein locus triplication causes Parkinson's disease. Science. 2003;302:841.
39.Nalls MA, et al. Large-scale meta-analysis identifies six new risk loci for Parkinson's. Nat Genet. 2014;46:989-993.
41.Egan MF, et al. BDNF val66met affects memory and hippocampal function. Cell. 2003;112:257-269.
49.Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000;408:239-247.
50.Willcox BJ, et al. FOXO3A genotype strongly associated with human longevity. PNAS. 2008;105:13987-13992.
51.Blackburn EH, et al. Human telomere biology: aging, disease risks, and protection. Science. 2015;350:1193-1198.
52.Imai S, Guarente L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 2014;24:464-471.
Reproductive & Endocrine Health
PCOS, endometriosis, fertility & thyroid
43.Sollid LM. Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol. 2002;2:647-655.
45.Chen ZJ, et al. GWAS identifies susceptibility loci for PCOS. Nat Genet. 2011;43:55-59.
46.Sapkota Y, et al. Meta-analysis identifies five novel loci associated with endometriosis. Nat Commun. 2017;8:15539.
21.Tomer Y. Mechanisms of autoimmune thyroid diseases. Annu Rev Pathol. 2014;9:147-156.
Scientific foundation
Precisya's systems biology view of human function
Human biology is not linear. Genetic variants, environmental exposures, nutrient sufficiency, inflammatory tone, endocrine balance, and stress signaling interact continuously across shared pathway terrain.
Precisya models this terrain using genomic interference patterns and biomarker observations to estimate where biological systems are stable, strained, or drifting toward dysfunction.
This is why the platform is presented not as a collection of tests, but as a precision health intelligence infrastructure one that treats human beings as multi-layer living systems.
Knowledge Graph
A structured biological intelligence layer linking genes, pathways, biomarkers, symptoms, and interventions across all major biological systems.
Metabolic Terrain Mapping
A terrain-based view of metabolism emphasising signal propagation rather than isolated lab flags or single-gene outputs.
Reverse Inference Logic
Interprets likely functional implications from interference patterns and observed biology providing probabilistic, not deterministic, interpretation.
Biomarker Anchoring
A practical bridge between genomic predisposition and real-world physiology connecting genetic risk to measurable biological state.
Restricted Research · Patent Pending
The Infinitesimal Hamiltonian
Biological Model
Precisya's foundational scientific framework models human biology as a dynamic energy landscape using Hamiltonian mechanics. Rather than episodic snapshots, the IHBM computes continuous biological trajectory, capacity state, and micro-intervention timing in real time.
Hₓ(t) = L(t) − R(t) + D(t)
22 Patent Claims
IHBM-WP-2025.4
FIG. 7 Preview · Longitudinal Capacity Trajectory
STABLE
70–100
SENSITIVE
45–69
OVERLOADED
0–44
LIVE SIM
B2B Platform Solutions
Power every partner's precision health offering
Precisya provides a modular precision and longevity intelligence platform that your clinic, hospital, app, or concierge service can integrate, brand as your own, and deploy to your patients: powered by our underlying intelligence engine.
10+
Deployable clinical modules
70+
Genetic panel integrations
6
Healthcare partner types served
22M+
Publications in scientific engine
⬡
Clinical differentiation
Add a premium precision health offering without building from scratch. Differentiate your practice or platform with advanced personalisation backed by 15+ years of evidence.
◎
Patient retention & engagement
Improve engagement through structured reports and clear next steps. Extend care beyond the consultation with longitudinal health intelligence and measurable outcomes.
◈
Scalable deployment
Deploy across multiple sites or service lines. Interoperable with existing EMR, telehealth apps, and care management platforms through enterprise integration layers.
◆
New revenue streams
Generate new revenue through premium service expansion. Brand the platform as your own: white-label or semi-private-label: with full pricing and naming flexibility.
Partner Integration Model
We integrate with your care model
Four steps from partnership to live precision health delivery at your organisation: powered by Precisya's platform, branded as your own.
Step 01
⊕
Choose your modules
Select 1–3 core clinical modules that match your specialty: longevity, metabolic, brain health, or the full-body engine.
Step 02
◎
Brand and configure
Apply your brand, naming, duration, and add-ons: consultations, devices, labs, or aesthetic services: to build your patient offering.
Step 03
◈
Launch to patients
Deploy your programme through your clinic, app, or concierge service. Precisya handles data ingestion, analysis, and structured report generation.
Step 04
⬡
Deliver precision care
Your team delivers care with greater precision and continuity. Track progress and refine longitudinally across each patient's biological journey.
B2B Solution Architecture
Deployable clinical intelligence modules
Each module is a deployable enterprise offering built on Precisya's core precision health platform. Partners select the modules relevant to their specialty and patient population.
⬡
Core Platform
Baseline Intelligence Engine
Foundation module
A standardised precision health intake and risk-mapping layer. Establishes the patient's biological baseline across genetics, biomarkers, and lifestyle for onward module integration.
Best-fit partners
Polyclinics
Hospitals
Health Apps
🧠
Clinical Module
Cognitive & Mental Health Module
Brain · Mood · Stress
Personalised brain, mood, and stress insights derived from neurocognitive markers, sleep patterns, nutrient status, and stress physiology data layers.
Best-fit partners
Health Apps
Concierge Care
Specialty Clinics
❤️
Clinical Module
Cardio-Metabolic Module
Lipids · Glucose · Vascular
Risk stratification for metabolic and vascular health. Covers lipid profiles, glucose markers, inflammation, vascular risk, and genetic predisposition to cardiometabolic conditions.
Best-fit partners
Hospitals
Polyclinics
Longevity Clinics
🛡️
Clinical Module
Immune & Inflammation Module
Immunity · Autoimmune · Burden
Flags immune burden, inflammatory patterns, and autoimmune risk using immune markers, inflammatory load scoring, genetic predisposition, and exposure profiling.
Best-fit partners
Specialty Clinics
Preventive Programmes
✦
Clinical Module
Cellular Renewal Module
Detox · Oxidative · Nutrients
Oxidative stress, detox pathway genetics, and nutrient optimisation. Interprets mitochondrial function and cellular resilience with lifestyle and environment as modulating factors.
Best-fit partners
Longevity Clinics
Wellness Providers
🌿
Clinical Module
Gut Intelligence Module
Digestive · Microbiome · Absorption
Digestive and microbiome-related assessment covering digestive markers, nutrient absorption, food sensitivity signals, and microbiome-relevant genetic patterns.
Best-fit partners
Functional Medicine
Specialty Clinics
🌙
Clinical Module
Sleep & Recovery Module
Circadian · Fatigue · Recovery
Recovery, circadian, and fatigue analytics. Maps sleep pattern genetics, stress signal burden, cortisol axis function, and recovery indicator profiles for performance-oriented care.
Best-fit partners
Concierge Medicine
Health Apps
⊕
Clinical Module
Structural & Aesthetic Module
Mobility · Tissue · Composition
Musculoskeletal markers, connective tissue signals, body composition, and movement profile intelligence for mobility-oriented and aesthetic medicine deployments.
Best-fit partners
Longevity Clinics
Aesthetic Medicine
◉
Clinical Module
Respiratory & Sensory Module
Allergy · Breathing · Sensory
Allergy profile, respiratory markers, inflammatory burden, and environmental trigger mapping. Designed for ENT, allergy, and specialty care network deployments.
Best-fit partners
Polyclinics
Specialty Care Networks
◆
Full Platform
Full-Body Longevity Engine
Multi-system · Integrated · Premium
Multi-system integrated precision health layer combining all modules. Genetics, biomarkers, lifestyle, and multi-system risk mapping in a single longitudinal intelligence environment.
Best-fit partners
Hospitals
Premium Concierge
Longevity Platforms
Who We Serve
Built for healthcare organisations of every structure
Precisya's platform adapts to the complexity of your care model: whether you serve patients through large-scale clinical settings, concierge environments, or digital platforms.
🏥
Polyclinics & Hospitals
Integrate precision health intelligence into existing clinical workflows. Deploy standardised risk mapping across large patient populations with EMR interoperability.
💎
Concierge Medicine
Elevate your premium offering with white-label precision health programmes. Multi-month membership models and high-touch patient experiences powered by deep biological intelligence.
📱
Health Apps & Platforms
Embed precision health intelligence via API. Personalise your user experience with structured biomarker insights, risk profiling, and actionable care pathways at scale.
🔬
Specialty Clinics
Extend your specialty with targeted biological intelligence modules. From functional medicine to immunology, deploy condition-specific risk and pathway insights for deeper clinical context.
⏳
Longevity Clinics
Power longevity programmes with multi-system biological intelligence: cellular renewal, vascular health, cognitive resilience, and aging biomarkers in a unified patient view.
✦
Aesthetic & Wellness Groups
Add a science-backed biological intelligence layer to your aesthetic or wellness offering. Structural health, nutrient optimisation, and ageing pathway intelligence for differentiated positioning.
Turnkey Programme Catalogue
Ready-made programmes for your patients
Pre-built, coherent clinical journeys your organisation can instantly brand, price, and launch: powered by Precisya's intelligence engine beneath the surface.
White-label & semi-private-label flexibility
Each programme blueprint is designed to be branded as your own. Clinics, apps, concierge operators, and specialty providers can apply unique names, pricing, and service bundles. You choose which modules to combine, how to integrate labs or devices, and how patients receive check-ins. Your logo, your pricing, your patient journey: powered by Precisya's underlying intelligence.
Platform Architecture
Enterprise integration built for healthcare
Precisya's solution stack is architected for clinical interoperability, operational efficiency, and seamless deployment within your existing care infrastructure.
Core Platform
The biological intelligence engine: 22M+ publications, pathway logic, genetic interference modeling, and multi-ethnicity precision breakdown analysis as a single deployable layer.
Provider Dashboard
Clinical-grade interface for your practitioners. Patient risk mapping, longitudinal health tracking, biomarker correlation views, and actionable intervention recommendations.
Patient Experience Layer
Structured, patient-facing reports and next-step pathways. Branded as your own, delivered at the right moment in the patient journey: clear, personalised, and actionable.
Insights & Reporting Layer
Population-level intelligence for your clinical and management teams. Risk cohort visibility, programme performance metrics, and longitudinal outcomes reporting at scale.
Enterprise Integration Layer
Interoperable with your existing EMR, telehealth, and lab systems. API-first architecture supporting digital-only, hybrid, and in-clinic deployment models.
Clinical Modules
10 deployable precision health modules that can be independently configured, combined, and white-labelled to match your clinical specialty and patient population.
Begin your partnership
Ready to power precision health delivery
for your patients?
for your patients?
Speak with the Precisya team about tailoring the intelligence platform to your organisation: from a single clinical module to a full-platform enterprise deployment.
Genetic Panels
Over 70 clinically actionable panels across every major medical discipline
Precisya has meticulously developed a diverse array of genetic panels tailored to meet the specific needs of different medical disciplines. Each panel delivers detailed, clinically actionable insights: customisable to each clinician's terminology, methodology, and patient care approach.
Why Now?
The gap no one is filling
In today's healthcare landscape, the potential to prevent and treat diseases through genetic understanding is monumental: yet underexploited. Each year, over 2 million scientific articles are published, yet no mechanism exists to update genetic tests in real-time with these findings.
Most available genetic tests focus on the Exome: just 2% of DNA: while neglecting vast intronic regions that regulate gene expression and protein function. They fail to show how genes interact, or their collective impact on health.
Precisya fills that gap: with a system that translates complex genetic data into actionable clinical decisions.
Our Focus Areas
Preventive Care
Chronic Diseases
Longevity Protocol
Precision Medicine
Pharmacogenomics
Precision Health personalises your care
Our genetic makeup determines how environmental effects are triggered and experienced. Precision health takes genes, family history, lifestyle, and clinical data into account: customising treatments and prevention plans for each individual. It enables doctors to understand the patient's body better and find the most effective treatments with minimal side effects.
Competitive Differentiators
Why Precisya outperforms every alternative
Six proprietary capabilities that no competitor has replicated. Each one compounds the others to deliver a precision health system that is scientifically, technically, and clinically superior.
01
Maximum Gene Coverage
While competitors analyse a handful of genes per condition, Precisya analyses hundreds to thousands. The human body has an average of 6 million variants. The closer we get to that number, the higher the precision of every result.
800,000+ variants per batch
vs 280,000 in NGS Exome
Genes analysed per condition
Nutrition
Competitors: 21
Precisya: 952 genes / 1,939 variants
Breast Cancer
Competitors: 2
Precisya: 178 genes / 362 variants
Cardiovascular
Competitors: 15
Precisya: 758 genes / 1,508 variants
Strand inversion: accuracy gain
100%
Without SIA
Baseline
+
+24%
Strand Inversion
SIA gain
=
World
#1
#1
With Precisya
Best in class
The Strand Inversion Algorithm corrects allele orientation errors that all competitors miss, delivering over 24% greater accuracy than any laboratory worldwide.
02
Strand Inversion Algorithm
A proprietary algorithm that calculates when the result of a substitution (allele) or genotype must be inverted. Without this correction, genetic risk scores can be systematically wrong. This is a critical step that every competitor in the world skips.
+24% accuracy gain
Proprietary IP
03
Ethnicity Precision Breakdown
No competitor accounts for ethnicity variation in their risk calculations. This causes systematically inaccurate results across diverse populations. Precisya applies complex multi-ethnicity formulas to compute each patient's calibrated Ethnicity-Based Score of Risk (EBSR).
Multi-ethnic calibration
EBSR scoring model
EBSR: same genotype, different populations
Condition: High LDL-Cholesterol (GG genotype)
HIGH
Eth1
Eth2
Patient 60%
Eth3
Eth4
Eth5
Eth6
Without Eth3 calibration: Risk = HIGH (3.0) | With EBSR: Calibrated = MEDIUM-HIGH (1.80)
Same gene, same result, different true risk based on ethnicity composition. Only Precisya calculates this.
DNA coverage comparison
NGS (Exome)
Exons only
280,000 variants
Misses 98% of DNA
Precisya GbS
Full genome scope
800,000+ variants
Includes regulatory DNA
04
Genotyping by Sequencing
NGS (Exome) analyses less than 2% of DNA. It targets only exons, the protein-coding regions, ignoring introns entirely. Introns regulate gene expression and protein function. Without them, the picture is dangerously incomplete. Precisya analyses both, at a minimum of 800,000 variants per batch.
Exons + Introns
800k+ variants per batch
05
Real-Time Big Data Engine
Built over 15 years of dedicated research, Precisya has aggregated 22M+ scientific publications into the world's largest proprietary genomic database. Powered by a Genomic Intelligence Layer of more than 12 proprietary algorithms, the system applies stringent inclusion and exclusion criteria, utilising only 6% of assessed publications for specific clinical output. The result is not volume but verified precision, and the engine continuously evolves, integrating new discoveries to keep every panel at the frontier of genomic science.
22M+ publications over 15 years
12+ proprietary algorithms
Only 6% inclusion rate
Genomic intelligence pipeline
📚
22M+ publications aggregated over 15 years
World's largest proprietary genomic database: PubMed, GWAS Catalog, ClinVar, Reactome, KEGG and more
↓
⚙️
12+ Proprietary Algorithms
Stringent inclusion/exclusion criteria: only 6% of assessed publications used
↓
🧬
Panels updated in real-time
No competitor does this at scale
Panel customisation layers
Base: Precisya Scientific Core
800k+ variants, pathway logic, EBSR scoring
Layer 2: Clinician Terminology
Your preferred language and clinical framing
Layer 3: Treatment Methodology
Your protocols, dosing preferences, intervention style
Layer 4: Personal Clinical Insights
Your experience integrated as an active intelligence layer
The result: a panel that is distinctly yours, powered by the world's most advanced genomic science.
06
Clinician Customisability
No two clinicians are the same, nor are their methods of treatment. Precisya lets doctors integrate their own terminologies, treatment methodologies, and clinical insights directly into the panel output. The result is not a generic report, but an intelligent extension of each clinician's practice.
4 customisation layers
Doctor-defined output
Panel Showcase
A selection from our 70+ panel catalog
The panels below represent a cross-section of Precisya's offering. Each entry shows the number of conditions and genetic variants analysed: figures that dwarf anything available in the market. Contact us for the full catalog.
Diabetes
33 conditions373 genes
Polygenic risk modeling for Type 2 Diabetes, insulin resistance, and metabolic syndrome pathways.
Nutrition
140 conditions1,071 genes
Comprehensive nutrigenomic profiling: vitamins, minerals, antioxidants, dietary metabolism and food sensitivities.
Cardiovascular
105 conditions734 genes
Atrial fibrillation, hypertension, lipid metabolism, thrombosis, and cardioembolic stroke risk.
Oncology
77 conditions518 genes
Hereditary cancer risk including breast, colorectal, pancreatic, lung, and haematological malignancies.
Metabolism & Hormones
219 conditions1,015 genes
Thyroid, adrenal, hormonal balance, cortisol pathways, and metabolic syndrome drivers.
Neurodegeneratives
62 conditions507 genes
Alzheimer's, Parkinson's, stroke, cognitive decline, and neurological risk stratification.
Woman's Health
94 conditions709 genes
PCOS, endometriosis, uterine fibroids, fertility, and hormone-driven conditions. Protection over prevention.
Longevity
83 conditions756 genes
Biological age drivers, telomere regulation, oxidative stress pathways, and anti-ageing intervention targets.
Autism
287 conditions1,449 genes
Comprehensive neurodevelopmental analysis spanning ASD, ADHD, and co-occurring behavioural conditions.
Man's Health
68 conditions647 genes
Male fertility, testosterone pathways, prostate risk, cardiovascular predisposition, and hormonal health.
Behavioural
134 conditions424 genes
Mood, addiction predisposition, anxiety, sleep, and neurochemical balance profiling.
Paediatrics & Baby Test
494 conditions1,551 genes
Early-life genetic profiling for congenital risk, developmental conditions, and preventive health planning from birth.
Full panel catalog available on request
The above represents a selection of our 70+ panel offering. Each panel is clinically actionable, scientifically grounded, and customisable to your practice. Contact us to receive the complete catalog with condition lists, gene counts, variant coverage, and integration specifications.
Personalized Metabolic Pathways
A pioneer in metabolic visualisation
Precisya's Personalized Metabolic Pathways tool offers an unparalleled visualisation of the body's most crucial metabolic pathways: providing healthcare professionals with rapid insights into functions, deficiencies, risks, and potential origins of existing or pre-existing diseases.
Comprehensive Coverage: maps inflammation, cardiovascular, neurotransmitter, hormonal, and metabolic pathways holistically
Deep Insights: identifies deficiencies and excesses, guiding effective treatment planning
Actionable Information: shows how specific genes influence pathway function, enzyme activity, and dietary metabolism
Patient-Specific: each map is generated from the individual patient's own genomic data
Sample pathway map structure
Methylation
Inflammation
Oxidative Stress
Cardiovascular
Insulin Signalling
Neurotransmitters
Thyroid
Mitochondria
Gut Microbiome
Each node maps to specific genes, variants, biomarkers, and clinical interventions unique to the patient's genomic profile.
How It Works
The Precisya precision health process
1
Sign Up
Patient enrols in the Precisya platform
→
2
Genomic Test
Patient DNA sequenced using Genotyping by Sequencing
→
3
Precisya Algorithm
Proprietary AI runs genomic data through 70+ panel logic
→
4
Blood & Metabolites
Patient blood tests correlated with genomic findings
5
Personalised Insights
Precision medicine, supplement & diet recommendations
→
6
Supplements
Precisya-supplied supplements & doctor-prescribed medications
→
7
Quarterly Check-ups
Blood tests & updated personalised recommendations every quarter
The opportunity
This is not just an opportunity: it is an imperative to transform the future of healthcare.
Continuous-Time Biological Intelligence
Precision Verticals
Intelligence
Precisya enables industries to be rebuilt on the foundation of genomic predisposition, biological state, contextual intelligence, and adaptive intervention: through the Infinitesimal Hamiltonian Biological Model at its core.
Patent Pending
IHBM-WP-2025.4
© 2025 Precisya Global Inc
The Precisya Model
From genetic truth to industry-scale biological intelligence.
Core IHBM Framework
[Proprietary formulation · Patent Pending]
Available under executed NDA with Precisya Global Inc
4
primary input domains
3
capacity states: Stable, Sensitive, Overloaded
≤10m
micro-intervention timing
∞
expandable vertical architecture
Infrastructure Thesis
We do not merely analyse biology. We operationalize it.
Precisya is structured as a precision health intelligence infrastructure company. Genetic information forms the foundational layer, but the real edge comes from how that information is computationally transformed into live biological intelligence that partners can use to create new categories, new services, and new revenue systems.
From static healthcare to dynamic biological infrastructure
Traditional solutions stop at predisposition, diagnostics, or episodic monitoring. Precisya connects predisposition to expression, expression to capacity, and capacity to action. This creates a new operating model where biology becomes interpretable across time, across environments, and across industries.
Why this matters for partners
Our partners do not need to become genomics companies. They can build their own vertical leadership while Precisya supplies the underlying biological intelligence layer, the systems framework, and the computational edge required to create differentiated and defensible offerings.
Layer 1
Genetic Foundation
Predisposition mapping establishes the biological base layer and personalized weighting logic for future interpretation.
Layer 2
IHBM Computational Engine
The Infinitesimal Hamiltonian Biological Model converts human biology into a continuous-time energy system where load, recovery, and dissipation can be modeled as trajectories rather than snapshots. (Proprietary formulation: patent pending.)
Layer 3
Infinitesimal Intervention Logic
Micro-actions are prioritized in the right biological moment to alter trajectory, reduce entropy, and improve capacity over time.
Layer 4
Vertical Intelligence Systems
Domain-specific applications for women's hormonal intelligence, sports performance, children's development, longevity, corporate wellbeing, and future verticals still to be born.
Vertical Partner Ecosystem
Precisya Precision Health Vertical Partners
Precisya is designed to help category partners build market-facing verticals on top of a reusable scientific core. Through genomic intelligence, metabolic pathway interpretation, biomarker correlation, and governed delivery logic, Precisya becomes the infrastructure layer beneath differentiated partner businesses in nutraceuticals, women's hormonal wellness, sports performance, and education.
4
Strategic partner expressions
1
Shared biological intelligence core
Many
Scalable domain-specific offerings
Why this matters
Most companies build a single product. Precisya enables an ecosystem. Each partner can own a branded market vertical while leveraging a deeper intelligence layer for discovery, intervention design, personalisation, and long-term recurring value creation.
Four partner pathways
Each vertical below is positioned not as a disconnected product idea, but as a category-defining partner expression that becomes stronger when linked to Precisya's genomic interpretation, metabolic pathway mapping, inflammation logic, and intervention architecture.
Nutraceuticals Partner
Nanyang Biologics
Nature, AI, molecular discovery, and translational nutraceutical opportunity
Nanyang Biologics sits at the intersection of nature-derived compound discovery, AI-led screening, and translational wellness product development. Their platform is oriented toward metabolic health, inflammation, oncology, and nutraceutical product development.
Can use Precisya's genomic intelligence to identify population-specific vulnerability clusters in cardiometabolic disease, inflammatory load, methylation, oxidative stress, and chronic disease progression.
Can use Precisya's metabolic pathway interpretation to prioritize target mechanisms for nutraceutical formulation rather than selecting compounds only by ingredient popularity.
Especially relevant for cardiovascular support, inflammation suppression, insulin resistance, fatty liver, metabolic dysregulation, and recovery-oriented functional nutrition.
Precisya leverage thesis
Precisya can help Nanyang move from compound discovery to precision formulation strategy, matching bioactive candidates to genomic burden, metabolic pathway interference, and disease-stage logic so nutraceutical design becomes more targeted, evidence-framed, and commercially differentiated.
Women's Hormonal Wellness Partner
Cellestra LifeTech Pte Ltd
Precision hormonal intelligence for women across lifecycle stages
Cellestra is positioned as a precision hormonal intelligence platform for women, combining deep genomics, biomarker integration, and AI-driven protocol generation across six health verticals and six lifecycle stages from adolescence through post-menopause.
Can be further strengthened by Precisya's genomic intelligence infrastructure and allostatic/metabolic pathway modeling to deepen hormonal-cascade interpretation beyond symptom clusters.
Particularly powerful in PCOS, perimenopause, adolescent hormonal mental health, fertility, and metabolic-liver cascade states where upstream-to-downstream biological propagation matters.
Precisya's pathway logic can improve research around inflammation, methylation, cortisol burden, thyroid conversion, and neuro-hormonal resilience.
Precisya leverage thesis
With Precisya beneath it, Cellestra evolves from a differentiated hormonal platform into a deeper hormonal intelligence operating system, mapping genomic risk, biomarker confirmation, metabolic propagation, allostatic stress burden, and intervention timing in an integrated way.
Sports Performance Partner
Sports Sync Inc, USA
Precision sports intelligence from cricket performance to collision-sport readiness
Sports Sync's sports-performance thesis aligns strongly with Precisya's biology-first architecture. The model translates genomics, blood biomarkers, and neurological profiling into role mapping, readiness scoring, injury intelligence, nutrition strategy, and pressure-response support.
For cricket, Precisya enables role suitability, trainable ceiling analysis, metabolic vulnerability detection, and longitudinal monitoring rather than generic sports science reporting.
For American football and high-collision sports, extended into recovery load, inflammation control, neurological resilience, soft-tissue risk, heat tolerance, and position-specific adaptation logic.
Precisya's metabolic pathway interpretation converts athlete biology into performance architecture, linking energy systems, oxidative stress, methylation, and recovery kinetics to actionable decisions.
Precisya leverage thesis
Precisya allows Sports Sync to move beyond performance dashboards into true biological performance infrastructure, where player development, readiness, injury prevention, and long-term athlete value are shaped through a reusable precision intelligence engine.
Education Vertical Partner
Genobyte Malaysia
Launching the education vertical with Clanbridge International School, Malaysia
Genobyte's education vertical can become a strong regional expression of Precisya's Precision Children Principle Model, a multi-stakeholder intelligence architecture integrating genomics, biomarkers, behavioural observation, and protocol logic across school, clinical, and home environments.
Can help schools move from one-size-fits-all wellbeing programmes toward individualised guidance in cognition, nutrition, sleep, mental health, digital wellbeing, and activity patterns.
Can support teachers, parents, counsellors, and clinicians through role-appropriate interfaces for earlier and better-coordinated intervention.
For Malaysia, this creates a credible precision education-health offering with strong relevance to premium schools, future human capital outcomes, and institutional partner expansion.
Precisya leverage thesis
Through Precisya, Genobyte can position its school rollout not merely as a student wellness initiative, but as a precision human-capital platform that can scale from first institutional pilots into a broader education and youth development ecosystem.
Why investors, partners, and the market should pay attention
The strategic value of Precisya is not only in interpretation. It is in enabling multiple industries to commercialise biology more intelligently. Whether the partner is discovering compounds, designing women's hormonal offerings, improving athlete performance, or shaping student wellbeing, Precisya functions as the reusable precision intelligence infrastructure that reduces scientific reinvention and accelerates market creation.
Reusable coreOne genomic and pathway intelligence foundation can power many branded verticals.
Higher-value productsPartners can move from generic offerings to biologically targeted, evidence-framed solutions.
Better economicsSupports recurring SaaS, protocol, monitoring, licensing, and category-expansion revenue models.
Market defensibilityScientific depth, multi-stakeholder architecture, and compliance-aware deployment create stronger moats.
Leadership
The team built to lead Precisya to unicorn status
An elite, multi-disciplinary leadership team combining decades of expertise in life sciences, AI-driven health intelligence, enterprise commercialisation, and capital markets. Together they are executing a bold mission: to build the world's defining biological infrastructure company.
Radhakrishnan S P
President & Chief Executive Officer
Visionary architect of Precisya's global precision health infrastructure, driving the mission to make biological intelligence universally accessible.
Prof. Dr. Roberto Grobman
Chief Scientist
Distinguished scientist and cardiologist pioneering the genomic research and bioinformatics with extensive research experience on systems biology and Precision Health Spectrum dedicating his professional journey to the well-being of humanity.
Dr. Joshua Kriesel
Director, Investor Relations & Corporate Governance
Bridging scientific excellence and capital markets, steering Precisya's investor strategy and corporate governance toward unicorn-scale growth.
Mr. Christopher Vega
Chief Financial Officer
Financial architect building the capital foundation and fiscal discipline that will carry Precisya through its next phase of exponential global growth.
Mr. Gary Clark
Chief Commercial Officer
Seasoned commercial leader translating Precisya's scientific depth into enterprise partnerships and revenue growth across global markets.
Mr. Gunnar Ong
Director, Asia Pacific Operations
Spearheading Precisya's Asia Pacific expansion, opening high-growth markets across Southeast and Far East Asia with strategic precision.
United by a singular mission
Every member of the Precisya leadership team brings not just credentials, but conviction: the belief that biological intelligence will redefine how humanity understands and optimises health. With deep roots in genomics, finance, commercial strategy, and global operations, this team has the experience, the network, and the drive to make Precisya the world's first biological infrastructure unicorn.
Advisory Board
Guided by world-class advisors and thought leaders
Precisya's advisory board brings extraordinary depth in economics, genomics, finance, and governance, lending strategic perspective as we build the world's leading biological infrastructure company.
Roger W. Ferguson Jr.
Advisory Board Member
A globally acclaimed economist, attorney, and corporate leader who served as Vice Chairman of the U.S. Federal Reserve Board (1999–2006), President and CEO of TIAA (2008–2021) overseeing one of the largest retirement providers for teachers and academics, and Director on the board of Alphabet Inc. since 2016, contributing to strategic oversight and governance of the parent company of Google.
Dr. Claire Ann Francomano
Advisory Board Member
A distinguished physician-scientist and medical geneticist who served as Chief of the Medical Genetics Branch and Clinical Director at the National Human Genome Research Institute, leading landmark clinical-molecular genomics programs translating genome discoveries into patient care. A long-standing professor at Johns Hopkins University School of Medicine, she built and directed influential academic and clinical genetics initiatives shaping modern medical genetics.
Kenneth L. Peoples
Advisory Board Member
A seasoned banking, finance, and legal professional with over three decades of experience spanning regulatory, restructuring, and international advisory domains. Currently Chief Executive Officer of The Peoples Group Ltd., advising global institutions including the World Bank, USAID, and the Millennium Challenge Corporation. Previously President and CEO of the Farm Credit System Assistance Board, leading the restructuring of the $60 billion Farm Credit System.
Team and Global Reach
Validated across diverse populations and healthcare environments
Precisya operates across 14 countries strengthening scientific relevance and commercial credibility through multi-population validation.
Active in 14 countries
Our global presence ensures the Precisya platform is tested, validated, and refined across populations with diverse genetic backgrounds, healthcare systems, and environmental contexts.
Multi-population validation is a core scientific and commercial differentiator underpinning the accuracy of Precisya's multi-ethnicity precision breakdown analysis.
Europe
Institutional and cross-border positioning across multiple healthcare systems.
Middle East
Precision health adoption and strategic healthcare partnerships.
South America
Diverse population intelligence and pathway relevance.
Southeast & Far East Asia
Ethnicity-aware deployment and scalable regional expansion.
Where We Operate
14 countries. One mission.
Select any country below for partnership or service access enquiries. We will respond within one business day.
Europe
Middle East
Asia Pacific
South America
Click any country to send a partnership or service access enquiry directly to our team.
🌍 14 active markets
📧 [email protected]
Investors
A defensible infrastructure play in precision health
Precisya is building the infrastructure layer that converts biological complexity into decision intelligence across multiple markets not simply selling tests or reports.
Scientific moat
22M+ publication engine plus algorithms refined since 2011 create defensibility that extends well beyond panel inventory. The knowledge graph continues to compound in value.
Category position
Precision Health Intelligence Infrastructure bridges clinical, enterprise, and human optimisation use cases with a single underlying scientific platform.
Multi-market leverage
A single scientific stack powers healthcare, education, sports performance, corporate resilience, and longevity science multiple revenue pathways from one R&D investment.
R&D frontier advantage
The PQBGI framework positions Precisya at the frontier of biological intelligence research creating potential for first-mover advantage in quantum bioelectric health modeling.
Investor inquiries
To discuss investment opportunities, request detailed materials, or arrange a presentation, please contact the Precisya leadership team directly.
Resources
A layer for technical and scientific content
Scientific briefs, architecture overviews, and partner-facing intelligence available at the appropriate access tier.
Scientific resources
A layer for technical and scientific content.
Biological terrain mapping frameworks
Precision health intelligence architecture
Metabolic pathway interpretation methodology
Scientific validity & methodology whitepaper
Partner deployment and institutional use cases
Partner intelligence access
Protected partner pages allow selected collaborators to experience Precisya's biological intelligence interfaces.
Interactive modules including the Biological Intelligence Map, Metabolic Axis Map, and R&D Intelligence Framework are exclusively available to verified partners.